Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Netherlands
100%
Hepatic Resection
100%
Prognostic Factors
100%
Metastatic Melanoma
100%
Survival Factor
100%
Overall Survival
33%
Prolonged Survival
33%
Disease-free Survival
33%
Median Overall Survival
33%
Population-based Study
16%
Univariate Analysis
16%
Kaplan-Meier Curve
16%
Poor Prognosis
16%
Postoperative Complications
16%
Postoperative Mortality
16%
Curative Resection
16%
Clinical Factors
16%
Melanoma
16%
Number of Metastases
16%
Hepatic Metastasis
16%
Heterogeneous Studies
16%
Potential Prognostic Factors
16%
Pathological Factors
16%
Melanoma Metastasis
16%
PALGA
16%
Cytopathology
16%
Univariate Regression Analysis
16%
Survival Regression Analysis
16%
Wide Networks
16%
INIS
liver
100%
patients
100%
netherlands
100%
metastases
100%
melanomas
100%
range
44%
diseases
22%
women
11%
curves
11%
surgery
11%
mortality
11%
safety
11%
assessments
11%
hospitals
11%
regression analysis
11%
populations
11%
distribution
11%
men
11%
Medicine and Dentistry
Prognostic Factor
100%
Hepatectomy
100%
Metastatic Melanoma
100%
Overall Survival
66%
Disease Free Survival
33%
Histopathology
16%
Postoperative Complication
16%
Recurrent Disease
16%
Univariate Analysis
16%
Liver Metastasis
16%
Metastatic Carcinoma
16%
Kaplan Meier Method
16%
Surgical Mortality
16%
Cytopathology
16%
Melanoma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Metastatic Melanoma
100%
Disease Free Survival
50%
Postoperative Complication
25%
Recurrent Disease
25%
Liver Metastasis
25%
Surgical Mortality
25%
Melanoma
25%
Immunology and Microbiology
Overall Survival
100%
Disease Free Survival
50%
Surgical Mortality
25%